Cargando…
Hepatitis C virus infection and related liver disease: the quest for the best animal model
Hepatitis C virus (HCV) is a major cause of cirrhosis and hepatocellular carcinoma (HCC) making the virus the most common cause of liver failure and transplantation. HCV is estimated to chronically affect 130 million individuals and to lead to more than 350,000 deaths per year worldwide. A vaccine i...
Autores principales: | Mailly, Laurent, Robinet, Eric, Meuleman, Philip, Baumert, Thomas F., Zeisel, Mirjam B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724122/ https://www.ncbi.nlm.nih.gov/pubmed/23898329 http://dx.doi.org/10.3389/fmicb.2013.00212 |
Ejemplares similares
-
Adaptive Immunity to Hepatitis C Virus
por: Zeisel, Mirjam B., et al.
Publicado: (2009) -
Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
por: Xiao, Fei, et al.
Publicado: (2015) -
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015) -
Elucidating the differences in pathogenicity between hepatitis E virus genotypes: The quest continues
por: Vercouter, Ann‐Sofie, et al.
Publicado: (2018) -
Host-targeting therapies for hepatitis C virus infection: current developments and future applications
por: Crouchet, Emilie, et al.
Publicado: (2018)